Lack of association between DRD2 and OPRM1 genotypes and adiposity

International Journal of Obesity

Volumn 38, Issue 5, 2014, Pages 730-736

  Hardman, C A ^a   Rogers, P J ^b   Timpson, N J ^b   Munafo M R ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ALSPAC; candidate genes; dopamine; opioids

Indexed keywords

DOPAMINE 2 RECEPTOR; MU OPIATE RECEPTOR; DRD2 PROTEIN, HUMAN; OPRM1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DRD2 GENE; FEMALE; FOOD INTAKE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPRM1 GENE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; ADULT; EATING; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; OBESITY; PREGNANCY;

ADIPOSITY; ADULT; ALLELES; APPETITE REGULATION; BODY MASS INDEX; CHILD; EATING; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; PREGNANCY; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, MU;

EID: 84899927941     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.144     Document Type: Article

References (59)

1. Kwon JM, Goate AM. The candidate gene approach. Alcohol Res Health 2000; 24: 164-168.
2. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99.
3. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61.
4. Flint J, Munafò MR. Candidate and non-candidate genes in behavior genetics. Curr Opin Neurobiol 2013; 23: 57-61.
5. Sullivan PF. Spurious genetic associations. Biol Psychiatry 2007; 61: 1121-1126.
6. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3: 391-397.
7. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
8. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
9. WTCCC. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-678.
10. Maes HHM, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27: 325-351.
11. Wardle J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 2008; 87: 398-404.
12. Malis C, Rasmussen EL, Poulsen P, Petersen I, Christensen K, Beck-Nielsen H et al. Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. Obes Res 2005; 13: 2139-2145.
13. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
14. Day FR, Loos RJ. Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics 2011; 4: 222-238.
15. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010; 42: 949-960.
16. 2) in obesity with comorbid substance use disorder: A preliminary report. Pharmacogenetics 1996; 6: 297-305.
17. Davis CA, Levitan RD, Reid C, Carter JC, Kaplan AS, Patte KA et al. Dopamine for 'wanting' and opioids for 'liking': a comparison of obese adults with and without binge eating. Obesity 2009; 17: 1220-1225.
18. Noble EP, Noble RE, Ritchie T, Syndulko K, Bohlman MC, Noble LA et al. D2 dopamine receptor gene and obesity. Int J Eat Disord 1994; 15: 205-217.
19. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996; 20: 1-25.
20. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci 2003; 26: 507-513.
21. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999; 4: 290-296.
22. 2 receptor availability in healthy volunteers. Mol Psychiatry 1998; 3: 256-260.
23. 2 receptor gene. Mol Psychiatry 1998; 3: 261-265.
24. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004; 23: 540-545.
25. Volkow ND, Wang G-J, Telang F, Fowler JS, Thanos PK, Logan J et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors. NeuroImage 2008; 42: 1537-1543.
26. Wang G-J, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W et al. Brain dopamine and obesity. Lancet 2001; 357: 354-357.
27. Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002; 26: 713-728.
28. 2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 1993; 50: 176-185.
29. Spitz MR, Detry MA, Pillow P, Hu Y, Amos CI, Hong WK et al. Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res 2000; 20: 371-380.
30. Thomas GN, JAJH Critchley, Tomlinson B, Cockram CS, JCN Chan. Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol 2001; 55: 605-611.
31. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008; 322: 449-452.
32. Jenkinson CP, Hanson R, Cray K, Wiedrich C, Knowler WC, Bogardus C et al. Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians. Int J Obes 2000; 24: 1233-1238.
33. Southon A, Walder K, Sanigorski AM, Zimmet P, Nicholson GC, Kotowicz MA et al. The Taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab 2003; 16: 72-76.
34. Davis C, Zai C, Levitan RD, Kaplan AS, Carter JC, Reid-Westoby C et al. Opiates, overeating and obesity: a psychogenetic analysis. Int J Obes 2011; 35: 1347-1354.
35. Xu L, Zhang F, Zhang D-d, Chen X-d, Lu M, Lin R-y et al. OPRM1 gene is associated with BMI in Uyghur population. Obesity 2008; 17: 121-125.
36. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6: 95-108.
37. Li A, Meyre D. Challenges in reproducibility of genetic association studies: lessons learned from the obesity field. Int J Obes 2013; 37: 559-567.
38. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
39. Sovio U, Mook-Kanamori DO, Warrington NM, Lawrence R, Briollais L, Palmer CN et al. Association between common variation at the FTO locus and changes in body mass index from infancy to late childhood: the complex nature of genetic association through growth and development. PLoS Genet 2011; 7: e1001307.
40. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J et al. Cohort profile: the 'Children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 2013; 42: 111-127.
41. Golding J, Pembrey M, Jones R. ALSPAC-The Avon Longitudinal Study of Parents and Children. Paediatr Perinat Epidemiol 2001; 15: 74-87.
42. Ness A. The Avon Longitudinal Study of Parents and Children (ALSPAC): a resource for the study of the environmental determinants of childhood obesity. Eur J Endocrinol 2004; 151: U141-U149.
43. Wardle J, Brodersen NH, Cole TJ, Jarvis MJ, Boniface DR. Development of adiposity in adolescence: five year longitudinal study of an ethnically and socioeconomically diverse sample of young people in Britain. BMJ 2006; 332: 1130-1135.
44. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
45. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010; 34: 816-834.
46. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies 2006http://hydra. usc.edu/gxe.
47. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 2013; 14: 365-376.
48. Sterne JAC, Smith GD. Sifting the evidence-what's wrong with significance tests? BMJ 2001; 322: 226-231.
49. Simmons JP, Nelson LD, Simonsohn U. False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci 2011; 22: 1359-1366.
50. Munafò MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007; 12: 454-461.
51. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters b-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci 1998; 95: 9608-9613.
52. Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280: 32618-32624.
53. Johnson W, Turkheimer E. Gottesman II, Bouchard TJ. Beyond heritability: twin studies in behavioral research. Curr Dir Psychol Sci 2010; 18: 217-220.
54. Kilpelainen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218, 166 adults and 19, 268 children. PLoS Med 2011; 8: e1001116.
55. Timpson NJ, Wade KH, Davey Smith G. Mendelian randomization: application to cardiovascular disease. Curr Hypertens Rep 2012; 14: 29-37.
56. Freathy RM, Kazeem GR, Morris RW, Johnson PCD, Paternoster L, Ebrahim S et al. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol 2011; 40: 1617-1628.
57. Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, Davey Smith G et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 2012; 9: e1001212.
58. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomisation using FTO/MC4R genotype. Hypertension 2009; 54: 84-90.
59. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, Tybjaerg-Hansen A et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes 2011; 35: 300-308.